Tibet Rhodiola Pharmaceutical Holding Co (600211) — Cash Flow Quality Index
Tibet Rhodiola Pharmaceutical Holding Co (600211) has a Cash Flow Quality Index of 1.38x as of December 2025. Operating cash flow of CN¥297.86 Million exceeds net income of CN¥216.15 Million, indicating high earnings quality where cash backs reported profits. Explore 600211 cash generation efficiency to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Tibet Rhodiola Pharmaceutical Holding Co Cash Flow Quality Index (1999–2025)
Historical Cash Flow Quality Index for Tibet Rhodiola Pharmaceutical Holding Co across 25 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Tibet Rhodiola Pharmaceutical Holding Co cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Tibet Rhodiola Pharmaceutical Holding Co (1999–2025)
Year-by-year earnings quality comparison for Tibet Rhodiola Pharmaceutical Holding Co. For live market cap and the full company financial profile, see how much is Tibet Rhodiola Pharmaceutical Holding Co worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.09x | CN¥1.03 Billion | CN¥937.93 Million | ▲ +16.3% |
| 2024 | 0.94x | CN¥994.79 Million | CN¥1.06 Billion | ▼ -30.3% |
| 2023 | 1.35x | CN¥1.08 Billion | CN¥800.91 Million | ▼ -39.4% |
| 2022 | 2.23x | CN¥837.38 Million | CN¥375.28 Million | ▲ +29.7% |
| 2021 | 1.72x | CN¥366.53 Million | CN¥213.03 Million | ▲ +69.0% |
| 2020 | 1.02x | CN¥428.17 Million | CN¥420.66 Million | ▼ -34.0% |
| 2019 | 1.54x | CN¥489.59 Million | CN¥317.37 Million | ▲ +16.3% |
| 2018 | 1.33x | CN¥289.22 Million | CN¥218.09 Million | ▲ +239.7% |
| 2017 | 0.39x | CN¥91.46 Million | CN¥234.29 Million | ▼ -68.9% |
| 2016 | 1.25x | CN¥250.21 Million | CN¥199.40 Million | ▼ -15.0% |
| 2015 | 1.48x | CN¥133.93 Million | CN¥90.74 Million | ▲ +121.1% |
| 2014 | -7.00x | CN¥-141.40 Million | CN¥20.21 Million | ▼ -160.0% |
| 2013 | 11.65x | CN¥279.22 Million | CN¥23.96 Million | ▲ +532.5% |
| 2012 | 1.84x | CN¥56.20 Million | CN¥30.50 Million | ▲ +221.3% |
| 2011 | 0.57x | CN¥12.09 Million | CN¥21.09 Million | ▲ +629.7% |
| 2010 | 0.08x | CN¥1.90 Million | CN¥24.18 Million | ▼ -90.8% |
| 2009 | 0.86x | CN¥17.88 Million | CN¥20.84 Million | ▼ -76.6% |
| 2008 | 3.66x | CN¥21.46 Million | CN¥5.86 Million | ▼ -73.3% |
| 2006 | 13.70x | CN¥33.63 Million | CN¥2.46 Million | ▲ +205.3% |
| 2004 | 4.49x | CN¥26.90 Million | CN¥6.00 Million | ▼ -45.9% |
| 2003 | 8.30x | CN¥47.20 Million | CN¥5.69 Million | ▲ +156.3% |
| 2002 | 3.24x | CN¥32.85 Million | CN¥10.14 Million | ▲ +281.7% |
| 2001 | 0.85x | CN¥15.47 Million | CN¥18.24 Million | ▲ +47.5% |
| 2000 | 0.58x | CN¥20.55 Million | CN¥35.72 Million | ▲ +747.0% |
| 1999 | 0.07x | CN¥2.25 Million | CN¥33.08 Million | — |